Tengelmann led the $10m first close of a $12m funding round that will help on-demand massage provider Zeel expand to additional cities.

Blue Cross and Blue Shield Association led the oncology management company's funding round through its corporate venturing affiliate.

Biocodex led the round, which will fund the start of clinical studies for Maat's microbiome-based dysbiosis treatment this summer.

The virtual reality technology startup will use the capital raised through the oversubscribed series A round to grow its development and engineering teams.

The virtual reality headset startup raised the money in a Colopl-led round that also featured Samsung and Foxconn.

Fraunhofer spinout Nexwafe will use the capital to commercialise its silicon wafers for solar cells.

Baxalta's corporate venturing unit contributed to the $10m second tranche of the autoimmune disease drug developer's series A round, expected to close at $26m.

Evotec has spun out Topas Therapeutics, which is working on treatments for conditions including MS, also contributing to a series A round.

Evotec has spun out Topas Therapeutics, which is working on treatments for conditions including MS, also contributing to a series A round.